World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
119
Citations
91587
World Ranking
334
National Ranking
28

Medicine

D-Index
119
Citations
91587
World Ranking
3803
National Ranking
373

Overview

Dmitry I. Gabrilovich is affiliated with AstraZeneca in the United Kingdom. Their research spans multiple disciplines, primarily focusing on immunology, microbiology, medicine, and biochemistry, genetics, and molecular biology. The scientist has contributed extensively to fields such as immunology, molecular biology, oncology, pulmonary and respiratory medicine, and cancer research.

The core topics of their work involve immune cells in cancer, cancer immunotherapy and biomarkers, immune response and inflammation, ferroptosis and cancer prognosis, neutrophil, myeloperoxidase and oxidative mechanisms, phagocytosis and immune regulation, and immune cell function and interaction.

Key publications of Dmitry I. Gabrilovich include:

  • Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity, 2021, Nature Reviews Immunology
  • Redox lipid reprogramming commands susceptibility of macrophages and microglia to ferroptotic death, 2020, Nature Chemical Biology
  • Ferroptosis of tumour neutrophils causes immune suppression in cancer, 2022, Nature
  • Analysis of classical neutrophils and polymorphonuclear myeloid-derived suppressor cells in cancer patients and tumor-bearing mice, 2021, The Journal of Experimental Medicine
  • Therapeutic targeting of tumour myeloid cells, 2023, Nature Reviews Cancer

Frequent co-authors with whom Dmitry I. Gabrilovich has collaborated include:

  • Emilio Sanseviero
  • Andrew V. Kossenkov
  • Yulia Nefedova
  • Serge Y. Fuchs
  • Valerian E. Kagan

The scientist's work is frequently published in several prominent scientific venues. These include:

  • Cancer Research
  • Cancer Immunology Research
  • Nature Communications
  • Cancer Discovery
  • Cancer Cell

Best Publications

  • Myeloid-derived suppressor cells as regulators of the immune system.

    Dmitry I. Gabrilovich;Srinivas Nagaraj

  • Understanding the tumor immune microenvironment (TIME) for effective therapy.

    Mikhail Binnewies;Edward W. Roberts;Kelly Kersten;Vincent Chan

  • Coordinated regulation of myeloid cells by tumours

    Dmitry I. Gabrilovich;Suzanne Ostrand-Rosenberg;Vincenzo Bronte

  • Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells.

    Dmitry I. Gabrilovich;Dmitry I. Gabrilovich;Hailei L. Chen;Khaled R. Girgis;H. Thomas Cunningham

  • Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards

    Vincenzo Bronte;Sven Brandau;Shu Hsia Chen;Mario P. Colombo

  • Immunosuppressive Strategies that are Mediated by Tumor Cells

    Gabriel Adrián Rabinovich;Dmitry Gabrilovich;Eduardo Sotomayor

  • Subsets of Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice

    Je-In Youn;Srinivas Nagaraj;Michelle Collazo;Dmitry I. Gabrilovich

  • The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment.

    Vinit Kumar;Sima Patel;Evgenii Tcyganov;Dmitry I. Gabrilovich

  • Myeloid-Derived Suppressor Cells

    Dmitry I. Gabrilovich

  • Myeloid-derived suppressor cells coming of age.

    Filippo Veglia;Michela Perego;Dmitry Gabrilovich

  • Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer.

    Bond Almand;Joseph I. Clark;Ekaterina Nikitina;James van Beynen

  • Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity.

    Filippo Veglia;Emilio Sanseviero;Dmitry I. Gabrilovich

  • Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells.

    Tianhong Wang;Guilian Niu;Marcin Kortylewski;Lyudmila Burdelya

  • Altered recognition of antigen is a mechanism of CD8 + T cell tolerance in cancer

    Srinivas Nagaraj;Kapil Gupta;Vladimir Pisarev;Leo Kinarsky

  • Vascular Endothelial Growth Factor Inhibits the Development of Dendritic Cells and Dramatically Affects the Differentiation of Multiple Hematopoietic Lineages In Vivo

    Dmitry Gabrilovich;Tadao Ishida;Tsunehiro Oyama;Sophia Ran

  • Mechanisms and functional significance of tumour-induced dendritic-cell defects.

    Dmitry I. Gabrilovich

  • History of myeloid-derived suppressor cells

    James E. Talmadge;Dmitry I. Gabrilovich

  • HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment

    Cesar A. Corzo;Thomas Condamine;Lily Lu;Matthew J. Cotter

  • Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function

    Thomas Condamine;Dmitry I. Gabrilovich

  • Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein

    Pingyan Cheng;Cesar A. Corzo;Noreen Luetteke;Bin Yu

  • The Nature of Myeloid-Derived Suppressor Cells in the Tumor

    Microenvironment Kumar;Sima Patel;Evgenii Tcyganov;Dmitry I. Gabrilovich

Frequent Co-Authors

Scott J. Antonia
Scott J. Antonia Duke University
David P. Carbone
David P. Carbone The Ohio State University
Valerian E. Kagan
Valerian E. Kagan University of Pittsburgh
Lucia R. Languino
Lucia R. Languino Thomas Jefferson University
Vladimir A. Tyurin
Vladimir A. Tyurin University of Pittsburgh
Andrew V. Kossenkov
Andrew V. Kossenkov The Wistar Institute
Dario C. Altieri
Dario C. Altieri The Wistar Institute
Stella C. Knight
Stella C. Knight Imperial College London
David W. Speicher
David W. Speicher The Wistar Institute
Sunil Chada
Sunil Chada The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can open diverse career opportunities. Many professionals pursue advanced nursing roles to complement their immunology expertise. For example, understanding how much do dnp nurses make can help you evaluate the financial benefits of pursuing a Doctor of Nursing Practice (DNP) degree.

If your goal is to shift focus within nursing specialties, specialized programs such as acnp programs provide a pathway from Family Nurse Practitioner (FNP) roles to Acute Care Nurse Practitioner positions, which often intersect with immunology-related patient care.

Additionally, accelerated educational options like the accelerated fnp program offer a faster route for licensed nurses to become certified Family Nurse Practitioners, supporting quicker career advancement in immunology-focused healthcare settings.

For those new to nursing, exploring quality online rn programs for non nurses can provide foundational skills and open doors to nursing roles critical in immunology research and patient treatment.

Best Scientists Citing Dmitry I. Gabrilovich

Trending Scientists

Recently Published Articles